Dyne Therapeutics, Inc. DYN Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s total equity?
- Dyne Therapeutics, Inc. (DYN) reported total equity of $865.06M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total equity changed year-over-year?
- Dyne Therapeutics, Inc.'s total equity increased by 29.3% year-over-year, from $668.97M to $865.06M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total equity has grown at a 23.2% compound annual growth rate (CAGR), from $342.37M to $972.13M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.